These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs. Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738 [Abstract] [Full Text] [Related]
10. Thromboembolic disease and the steroidal content of oral contraceptives. Swyer GI. Res Reprod; 1970 Jul; 2(4):1. PubMed ID: 12254979 [Abstract] [Full Text] [Related]
11. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity. Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM. Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323 [Abstract] [Full Text] [Related]
12. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study. Kay CR. Am J Obstet Gynecol; 1982 Mar 15; 142(6 Pt 2):762-5. PubMed ID: 6801981 [Abstract] [Full Text] [Related]
17. [Hormonal contraception and substitution therapy: the importance of progestogen for cardiovascular diseases]. Kuhl H. Geburtshilfe Frauenheilkd; 1992 Nov 15; 52(11):653-62. PubMed ID: 1452000 [Abstract] [Full Text] [Related]